Selected article for: "aeruginosa pneumonia and Pseudomonas aeruginosa pneumonia"

Author: Gregorova, Michaela; Morse, Daniel; Brignoli, Tarcisio; Steventon, Joseph; Hamilton, Fergus; Albur, Mahableshwar; Arnold, David; Thomas, Matthew; Halliday, Alice; Baum, Holly; Rice, Christopher; Avison, Matthew B; Davidson, Andrew D; Santopaolo, Marianna; Oliver, Elizabeth; Goenka, Anu; Finn, Adam; Wooldridge, Linda; Amulic, Borko; Boyton, Rosemary J; Altmann, Daniel M; Butler, David K; McMurray, Claire; Stockton, Joanna; Nicholls, Sam; Cooper, Charles; Loman, Nicholas; Cox, Michael J; Rivino, Laura; Massey, Ruth C
Title: Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia
  • Cord-id: v22e74gs
  • Document date: 2020_12_17
  • ID: v22e74gs
    Snippet: Here, we describe the case of a COVID-19 patient who developed recurring ventilator-associated pneumonia caused by Pseudomonas aeruginosa that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and P. aeruginosa specific, and bystander activated, which may have contributed to this patient’s persi
    Document: Here, we describe the case of a COVID-19 patient who developed recurring ventilator-associated pneumonia caused by Pseudomonas aeruginosa that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and P. aeruginosa specific, and bystander activated, which may have contributed to this patient’s persistent symptoms and radiological changes.

    Search related documents: